David Baldwin

All Stories

1. 
   Structured triage of incidental findings in lung cancer screening: Outcomes from a UK programme

   Article • Lung Cancer, October 2026, Elsevier

   David Baldwin

2. 
   Patient preferences for the use of AI in chest X-ray result processing and communication

   Article • Radiography, October 2026, Elsevier

   David Baldwin

3. 
   Recruitment strategies for lung cancer screening; a randomised trial in the 4-IN-THE-LUNG-RUN study

   Article • Lung Cancer, August 2026, Elsevier

   David Baldwin

4. 
   Cost-effectiveness of immediate prioritisation of chest X-rays using artificial intelligence in lung cancer in England: the LungIMPACT study

   Article • July 2026, Springer Science + Business Media

   David Baldwin

5. 
   New conversations in an old argument: Lessons learnt from the PIONEER randomised feasibility study in resectable stage III-N2 NSCLC

   Article • Lung Cancer, June 2026, Elsevier

   David Baldwin

6. 
   How to Translate Quality Standards Into Good Lung Cancer Screening Programmes: The UK Experience

   Article • British Journal of Hospital Medicine, April 2026, IMR Press

   David Baldwin

7. 
   AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial

   Article • Nature Medicine, March 2026, Springer Science + Business Media

   David Baldwin

8. 
   Implementation of the NHS England Lung Cancer Screening Programme over 5 years

   Article • Nature Medicine, March 2026, Springer Science + Business Media

   David Baldwin

9. 
   Implementing AI innovation in radiology departments in the English NHS: a qualitative study on the experiences of professionals, patient groups and innovators

   Article • Frontiers in Digital Health, March 2026, Frontiers

   David Baldwin

10. 
    Randomised trial of delivering co-located, personalised stop-smoking support within lung cancer screening: the YESS study

    Article • Thorax, March 2026, BMJ

    David Baldwin

11. 
    A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening

    Article • Journal of Thoracic Oncology, February 2026, Elsevier

    David Baldwin

12. 
    59 Measuring the incidence of lymph node metastases in non-small cell lung cancer (NSCLC)≥ 3 cmaccording to CT and PET-CT findings

    Article • Lung Cancer, February 2026, Elsevier

    David Baldwin

13. 
    218 Outcomes of Multidisciplinary Review for Incidental Findings in Lung Cancer Screening: A Real-World Audit from the NHS LCSP (Nottingham)

    Article • Lung Cancer, February 2026, Elsevier

    David Baldwin

14. 
    287 Smoking cessation interventions in lung cancer screening: study protocol for a pragmatic, multi-centre randomised-controlled trial (the YorQuit study)

    Article • Lung Cancer, February 2026, Elsevier

    David Baldwin

15. 
    Health economic model to evaluate the cost-effectiveness of smoking cessation services integrated within lung cancer screening in the United Kingdom

    Article • Thorax, January 2026, BMJ

    David Baldwin

16. 
    State-of-the-Art Machine Learning Models for Detecting and Mitigating Disparities in Healthcare

    Article • January 2026, Springer Science + Business Media

    David Baldwin

17. 
    Towards Inclusive AI System Development for Disease Risk Prediction: Collecting, Prioritising and Incorporating User Stories from Heterogeneous Stakeholders

    Article • January 2026, Springer Science + Business Media

    David Baldwin

18. 
    Evaluating LIME and SHAP Under Class Imbalance: A Lung Cancer Prediction Case Study Using CPRD Data

    Article • January 2026, Springer Science + Business Media

    David Baldwin

19. 
    European Code Against Cancer, 5th edition – organised cancer screening programmes

    Article • Molecular Oncology, January 2026, Wiley

    David Baldwin

20. 
    European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer

    Article • Molecular Oncology, November 2025, Wiley

    David Baldwin

21. 
    Evaluating XAI techniques under class imbalance using CPRD data

    Article • Frontiers in Artificial Intelligence, November 2025, Frontiers

    David Baldwin

22. 
    Screening for lung cancer: A systematic review of overdiagnosis and its implications

    Article • Molecular Oncology, November 2025, Wiley

    David Baldwin

23. 
    Utilization of Lung Cancer Registries in Learning Health Systems for Health Care Improvement

    Article • JCO Clinical Cancer Informatics, November 2025, American Society of Clinical Oncology (ASCO)

    David Baldwin

24. 
    Effective management of incidental findings in lung cancer screening: the role of the screening review meeting

    Article • Clinical Radiology, August 2025, Elsevier

    David Baldwin

25. 
    Prospective Evaluation of Lung Cancer Screening Eligibility Criteria and Lung Cancer Detection in the Yorkshire Lung Screening Trial

    Article • Journal of Thoracic Oncology, April 2025, Elsevier

    David Baldwin

26. 
    66 Quantification of differences between semi-automated lung nodule volumetry software packages

    Article • Lung Cancer, February 2025, Elsevier

    David Baldwin

27. 
    Increasing Lung Screening uptake: Exploring people who smoke and their family members concerns and recommendations regarding screening invitations

    Article • Tobacco Prevention & Cessation, January 2025, E.U. European Publishing

    David Baldwin

28. 
    Explainable Boosting Machines for Lung Cancer Prediction and Explanation

    Article • January 2025, Springer Science + Business Media

    David Baldwin

29. 
    Decision Tree Models to Select High-Risk Patients for Lung Cancer Screening and Model Interpretability

    Article • January 2025, Springer Science + Business Media

    David Baldwin

30. 
    Ethnic disparities in lung cancer incidence and differences in diagnostic characteristics: a population-based cohort study in England

    Article • The Lancet Regional Health - Europe, January 2025, Elsevier

    David Baldwin

31. 
    Improving Healthcare Outcomes by Identifying Populations with Higher Risk of Lung Cancer from Primary Care Data

    Article • January 2025, Springer Science + Business Media

    David Baldwin

32. 
    Results from a Choice-Based Conjoint Experimental Study on Patients' Preferences for Chest X-Ray Results processing and Communications when Referred by their GP/ Primary Care Doctor in NHS, England

    Article • January 2025, Elsevier

    David Baldwin

33. 
    Achieving earlier diagnosis of symptomatic lung cancer

    Article • British Journal of General Practice, December 2024, Royal College of General Practitioners

    David Baldwin

34. 
    Quality assurance in lung cancer screening

    Article • British Journal of Radiology, November 2024, Oxford University Press (OUP)

    David Baldwin

35. 
    Pulmonary fibrosis and lung cancer: an analysis of the Clinical Practice Research Datalink linked to the National Cancer Registration Dataset

    Article • Thorax, September 2024, BMJ

    David Baldwin

36. 
    The incidence of lung cancer amongst primary care chest radiograph referrals—an evaluation of national and local datasets within the United Kingdom

    Article • British Journal of Radiology, August 2024, Oxford University Press (OUP)

    David Baldwin

37. 
    The importance of co-located, high intensity smoking cessation support within lung cancer screening: Findings from the Process Evaluation of the Yorkshire Enhanced Stop Smoking study

    Article • July 2024, Cold Spring Harbor Laboratory Press

    David Baldwin

38. 
    UK Stakeholder Perspectives on Surrogate Endpoints in Cancer, and the Potential for UK Real-World Datasets to Validate Their Use in Decision-Making

    Article • Cancer Management and Research, July 2024, Taylor & Francis

    David Baldwin

39. 
    Understanding Feature Importance of Prediction Models Based on Lung Cancer Primary Care Data

    Article • June 2024, Institute of Electrical & Electronics Engineers (IEEE)

    David Baldwin

40. 
    Uptake and 4-week quit rates from an opt-out co-located smoking cessation service delivered alongside community-based low-dose computed tomography screening within the Yorkshire Lung Screening Trial

    Article • European Respiratory Journal, April 2024, European Respiratory Society (ERS)

    David Baldwin

41. 
    137 A Randomised Controlled Feasibility Trial of Surgery versus No Surgery as Part of Multi-Modality Treatment in Stage III – N2 Non-Small Cell Lung Cancer

    Article • Lung Cancer, April 2024, Elsevier

    David Baldwin

42. 
    Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer

    Article • Journal of Thoracic Oncology, January 2024, Elsevier

    David Baldwin

43. 
    Determining the impact of an artificial intelligence tool on the management of pulmonary nodules detected incidentally on CT (DOLCE) study protocol: a prospective, non-interventional multicentre UK study

    Article • BMJ Open, January 2024, BMJ

    David Baldwin

44. 
    Cost-effectiveness of volume computed tomography in lung cancer screening: a cohort simulation based on Nelson study outcomes

    Article • Journal of Medical Economics, December 2023, Taylor & Francis

    David Baldwin

45. 
    Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset

    Article • Thorax, November 2023, BMJ

    David Baldwin

46. 
    P10 ‘Something like a house of horrors’: a mixed methods study examining the reasons for refusal of potentially curative treatment in early-stage lung cancer

    Article • November 2023, BMJ

    David Baldwin

47. 
    S32 Implementing lung cancer screening in the UK: baseline results from the NHS England national ‘targeted lung health check’ programme

    Article • November 2023, BMJ

    David Baldwin

48. 
    ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

    Article • European Journal of Cardio-Thoracic Surgery, October 2023, Oxford University Press (OUP)

    David Baldwin

49. 
    ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer

    Article • European Respiratory Journal, October 2023, European Respiratory Society (ERS)

    David Baldwin

50. 
    Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review

    Article • BMC Cancer, September 2023, Springer Science + Business Media

    Dr Samuel Merriel, Dr Dipesh P Gopal, David Baldwin

51. 
    Measuring Harms of Lung Cancer Screening

    Article • CHEST Journal, August 2023, Elsevier

    David Baldwin

52. 
    Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models

    Article • The Lancet Respiratory Medicine, August 2023, Elsevier

    David Baldwin

53. 
    Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD

    Article • ERJ Open Research, July 2023, European Respiratory Society (ERS)

    David Baldwin

54. 
    The Impact of COVID-19 on Lung Cancer Incidence in England

    Article • CHEST Journal, June 2023, Elsevier

    David Baldwin

55. 
    Developing a pan-European technical standard for a comprehensive high-quality lung cancer computed tomography screening programme: an ERS technical standard

    Article • European Respiratory Journal, May 2023, European Respiratory Society (ERS)

    David Baldwin

56. 
    Defining the road map to a UK national lung cancer screening programme

    Article • The Lancet Oncology, May 2023, Elsevier

    David Baldwin

57. 
    Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals

    Article • JAMA Network Open, March 2023, American Medical Association (AMA)

    David Baldwin

58. 
    Lung cancer screening

    Article • The Lancet, February 2023, Elsevier

    David Baldwin

59. 
    Lung nodules: sorting the wheat from the chaff

    Article • British Journal of Radiology, February 2023, Oxford University Press (OUP)

    David Baldwin

60. 
    Clinical trials in cancer screening, prevention and early diagnosis (SPED): A systematic mapping review

    Article • January 2023, Research Square

    David Baldwin, Dr Dipesh P Gopal

61. 
    Important parameters for cost-effective implementation of lung cancer screening

    Article • British Journal of Radiology, January 2023, Oxford University Press (OUP)

    David Baldwin

62. 
    Decision Tree Approaches to Select High Risk Patients for Lung Cancer Screening Based on the UK Primary Care Data

    Article • January 2023, Springer Science + Business Media

    David Baldwin

63. 
    Logistic Regression Approach to a Joint Classification and Feature Selection in Lung Cancer Screening Using CPRD Data

    Article • January 2023, Springer Science + Business Media

    David Baldwin

64. 
    Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context

    Article • BMC Pulmonary Medicine, December 2022, Springer Science + Business Media

    David Baldwin

65. 
    European Respiratory Society guideline on various aspects of quality in lung cancer care

    Article • European Respiratory Journal, November 2022, European Respiratory Society (ERS)

    David Baldwin, Prof Luciano Mutti

66. 
    Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial

    Article • Thorax, November 2022, BMJ

    David Baldwin

67. 
    An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership

    Article • Cancer Control, October 2022, SAGE Publications

    David Baldwin

68. 
    Decision Support Tools for Low-Dose CT Lung Cancer Screening

    Article • CHEST Journal, October 2022, Elsevier

    David Baldwin

69. 
    Co-development of an evidence-based personalised smoking cessation intervention for use in a lung cancer screening context

    Article • July 2022, Cold Spring Harbor Laboratory Press

    David Baldwin

70. 
    Participation in community-based lung cancer screening: the Yorkshire Lung Screening Trial

    Article • European Respiratory Journal, July 2022, European Respiratory Society (ERS)

    David Baldwin

71. 
    Predicting the future risk of lung cancer: development and validation of QCancer2 (10-year risk) lung model and evaluating the model performance of nine prediction models

    Article • June 2022, Cold Spring Harbor Laboratory Press

    David Baldwin

72. 
    Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think‐aloud study

    Article • Health Expectations, June 2022, Wiley

    David Baldwin

73. 
    The role of computer-assisted radiographer reporting in lung cancer screening programmes

    Article • European Radiology, May 2022, Springer Science + Business Media

    David Baldwin

74. 
    Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend

    Article • Health Expectations, May 2022, Wiley

    David Baldwin

75. 
    Implementing Lung Cancer Screening in Europe: Taking a Systems Approach

    Article • JTO Clinical and Research Reports, May 2022, Elsevier

    David Baldwin

76. 
    Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit

    Article • Thorax, April 2022, BMJ

    David Baldwin

77. 
    196P An international consensus on actions to improve lung cancer survival: A clinical review by the international cancer benchmarking partnership (ICBP)

    Article • Annals of Oncology, April 2022, Elsevier

    David Baldwin

78. 
    Lung Cancer in the United Kingdom

    Article • Journal of Thoracic Oncology, February 2022, Elsevier

    David Baldwin

79. 
    Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks

    Article • Journal of Thoracic Oncology, February 2022, Elsevier

    David Baldwin

80. 
    The Future of Lung Cancer Screening: Current Challenges and Research Priorities

    Article • Cancer Management and Research, February 2022, Taylor & Francis

    David Baldwin

81. 
    Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

    Article • The Lancet Respiratory Medicine, November 2021, Elsevier

    MD Pilar Rivera Ortega, Dr Omer Elneima, Prof Nicholas Hart, Prof. Markus Ralser, Trudie Chalder, Dr Stephen P McAdoo, David Baldwin, Dr dan Wootton

82. 
    Analysis of the baseline performance of five UK lung cancer screening programmes

    Article • Lung Cancer, November 2021, Elsevier

    David Baldwin

83. 
    Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis

    Article • The Lancet Regional Health - Europe, November 2021, Elsevier

    David Baldwin

84. 
    Selection of eligible participants for screening for lung cancer using primary care data

    Article • Thorax, October 2021, BMJ

    David Baldwin

85. 
    What is the Definition of Cure in Non-small Cell Lung Cancer?

    Article • Oncology and Therapy, August 2021, Springer Science + Business Media

    David Baldwin

86. 
    International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study

    Article • Thorax, July 2021, BMJ

    David Baldwin

87. 
    Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)

    Article • BMJ Open Respiratory Research, July 2021, BMJ

    David Baldwin

88. 
    Correction: Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

    Article • British Journal of Cancer, May 2021, Springer Science + Business Media

    David Baldwin

89. 
    Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom

    Article • British Journal of Cancer, April 2021, Springer Science + Business Media

    David Baldwin

90. 
    Factors associated with survival in small cell lung cancer: an analysis of real-world national audit, chemotherapy and radiotherapy data

    Article • Annals of Palliative Medicine, April 2021, AME Publishing Company

    David Baldwin

91. 
    Participation in lung cancer screening

    Article • Translational Lung Cancer Research, February 2021, AME Publishing Company

    David Baldwin

92. 
    S69 Lung cancer screening – cumulative results from five UK-based programmes

    Article • January 2021, BMJ

    David Baldwin

93. 
    Importance of research design in biomarkers for lung cancer

    Article • European Respiratory Journal, January 2021, European Respiratory Society (ERS)

    David Baldwin, David Baldwin

94. 
    Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation

    Article • Journal of Thoracic Oncology, January 2021, Elsevier

    David Baldwin

95. 
    Selecting Lung Cancer Patients from UK Primary Care Data: A Longitudinal Study of Feature Trends

    Article • January 2021, Springer Science + Business Media

    David Baldwin

96. 
    Reply to Wilson: Improving Lung Cancer Screening Uptake

    Article • American Review of Respiratory Disease, October 2020, American Thoracic Society

    Angshu Bhowmik, David Baldwin

97. 
    Pulmonary nodules

    Article • BMJ, October 2020, BMJ

    David Baldwin

98. 
    New fissure-attached nodules in lung cancer screening: more practical implications from the NELSON study?

    Article • Translational Lung Cancer Research, October 2020, AME Publishing Company

    David Baldwin

99. 
    An update on CT screening for lung cancer: the first major targeted cancer screening programme

    Article • British Journal of Radiology, September 2020, British Institute of Radiology

    David Baldwin

100. 
     Towards personalized lung cancer CT screening in Europe

     Article • September 2020, European Respiratory Society (ERS)

     David Baldwin

101. 
     Yorkshire Enhanced Stop Smoking (YESS) study: a protocol for a randomised controlled trial to evaluate the effect of adding a personalised smoking cessation intervention to a lung cancer screening programme

     Article • BMJ Open, September 2020, BMJ

     David Baldwin

102. 
     Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk

     Article • BMJ Open, September 2020, BMJ

     David Baldwin

103. 
     Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer

     Article • CHEST Journal, September 2020, Elsevier

     David Baldwin

104. 
     Lung Screen Uptake Trial: results from a single lung cancer screening round

     Article • Thorax, August 2020, BMJ

     Angshu Bhowmik, David Baldwin

105. 
     Targeted screening for lung cancer is here but who do we target and how?

     Article • Thorax, July 2020, BMJ

     David Baldwin

106. 
     SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection

     Article • European Respiratory Journal, July 2020, European Respiratory Society (ERS)

     David Baldwin

107. 
     Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort

     Article • Annals of the American Thoracic Society, July 2020, American Thoracic Society

     Angshu Bhowmik, David Baldwin

108. 
     Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe

     Article • Cancers, June 2020, MDPI AG

     David Baldwin, Dr. Luca Bertolaccini

109. 
     Lung Screen Uptake Trial (LSUT): Randomized Controlled Clinical Trial Testing Targeted Invitation Materials

     Article • American Review of Respiratory Disease, April 2020, American Thoracic Society

     Angshu Bhowmik, David Baldwin

110. 
     Lung cancer: investigation and staging

     Article • Medicine, April 2020, Elsevier

     David Baldwin

111. 
     External validation of a convolutional neural network artificial intelligence tool to predict malignancy in pulmonary nodules

     Article • Thorax, March 2020, BMJ

     David Baldwin

112. 
     A systematic review of survival following anti-cancer treatment for small cell lung cancer

     Article • Lung Cancer, March 2020, Elsevier

     David Baldwin

113. 
     Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England

     Article • Thorax, December 2019, BMJ

     David Baldwin

114. 
     Correction:Defining the information needs of lung cancer screening participants: a qualitative study

     Article • BMJ Open Respiratory Research, December 2019, BMJ

     David Baldwin

115. 
     S21 Developing NHS england’s national targeted lung health check pilot

     Article • November 2019, BMJ

     David Baldwin

116. 
     P78 The role of computer-assisted radiographer reporting in lung cancer screening programmes

     Article • November 2019, BMJ

     David Baldwin

117. 
     Defining the information needs of lung cancer screening participants: a qualitative study

     Article • BMJ Open Respiratory Research, November 2019, BMJ

     David Baldwin

118. 
     Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening

     Article • European Journal of Radiology, November 2019, Elsevier

     David Baldwin

119. 
     P2.11-07 Benefits and Harms of Contemporary Lung Cancer Screening: An Infographic to Support Public and Patient Education

     Article • Journal of Thoracic Oncology, October 2019, Elsevier

     David Baldwin

120. 
     S01.14 Lung Cancer MDT

     Article • Journal of Thoracic Oncology, October 2019, Elsevier

     David Baldwin

121. 
     P1.11-32 The UKLS Nodule Risk Model (UKLS-NRM): Utilising Nodule Volumetry

     Article • Journal of Thoracic Oncology, October 2019, Elsevier

     David Baldwin

122. 
     Evaluation of cardiovascular risk in a lung cancer screening cohort

     Article • Thorax, September 2019, BMJ

     Angshu Bhowmik, David Baldwin

123. 
     Ex vivo Raman spectroscopy mapping of lung tissue: label-free molecular characterization of nontumorous and cancerous tissues

     Article • Journal of Medical Imaging, August 2019, SPIE

     David Baldwin

124. 
     Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol

     Article • The Lancet Respiratory Medicine, August 2019, Elsevier

     Professor Peter Sasieni, David Baldwin

125. 
     Impact of a Lung Cancer Screening Information Film on Informed Decision-making: A Randomized Trial

     Article • Annals of the American Thoracic Society, June 2019, American Thoracic Society

     Angshu Bhowmik, David Baldwin

126. 
     Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial

     Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

     David Baldwin

127. 
     Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial

     Article • Thorax, April 2019, BMJ

     David Baldwin

128. 
     The potential of breath analysis to improve outcome for patients with lung cancer

     Article • Journal of Breath Research, April 2019, Institute of Physics Publishing

     David Baldwin

129. 
     Determining the factors associated with 1-year survival in small cell lung cancer using national audit, chemotherapy and radiotherapy data

     Article • Lung Cancer, January 2019, Elsevier

     David Baldwin

130. 
     Impact of radiographer immediate reporting of chest x-rays from general practice on the lung cancer pathway (radioX)

     Article • Lung Cancer, January 2019, Elsevier

     David Baldwin

131. 
     Implementation of the National Optimal Lung Cancer Pathway: the Nottingham experience

     Article • Lung Cancer, January 2019, Elsevier

     David Baldwin

132. 
     Optimising nodule management with data from the Lung Screen Uptake Trial

     Article • Lung Cancer, January 2019, Elsevier

     David Baldwin

133. 
     Performance of endobronchial ultrasound-guided transbronchial needle aspiration in PD-L1 testing in patients with NSCLC

     Article • Lung Cancer, January 2019, Elsevier

     David Baldwin

134. 
     Results from a prevalence round of LDCT screening for lung cancer in the Lung Screen Uptake Trial

     Article • Lung Cancer, January 2019, Elsevier

     David Baldwin

135. 
     Status of Lung Cancer Data Collection in Europe

     Article • JCO Clinical Cancer Informatics, December 2018, American Society of Clinical Oncology (ASCO)

     David Baldwin

136. 
     Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries

     Article • BMC Cancer, November 2018, Springer Science + Business Media

     Professor Alexandru Corlateanu, David Baldwin

137. 
     Lung cancer screening – gaining consensus on next steps – proceedings of a closed workshop in the UK

     Article • Lung Cancer, November 2018, Elsevier

     David Baldwin

138. 
     Factors influencing treatment selection and 30-day mortality after chemotherapy for people with small-cell lung cancer: An analysis of national audit data

     Article • European Journal of Cancer, November 2018, Elsevier

     David Baldwin

139. 
     ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe

     Article • European Respiratory Journal, October 2018, European Respiratory Society (ERS)

     Prof Luciano Mutti, David Baldwin

140. 
     EUPS—argues that lung cancer screening should be implemented in 18 months

     Article • British Journal of Radiology, October 2018, Oxford University Press (OUP)

     David Baldwin

141. 
     Lung cancer screening—low dose CT for lung cancer screening: recent trial results and next steps

     Article • British Journal of Radiology, October 2018, Oxford University Press (OUP)

     David Baldwin

142. 
     P1.12-12 A Systematic Review and Meta-Analysis of Early and Late Survival Following Anti-Cancer Therapies for Small Cell Lung Cancer

     Article • Journal of Thoracic Oncology, October 2018, Elsevier

     David Baldwin

143. 
     MS04.02 How Is Lung Cancer Screening Evolving to Be More Efficient and Effective?

     Article • Journal of Thoracic Oncology, October 2018, Elsevier

     David Baldwin

144. 
     P2.16-16 SABRTOOTH: A Fasibility Study of SABR Versus Surgery in Patients with Peripheral Stage I NSCLC Considered to be at Higher Risk for Surgery

     Article • Journal of Thoracic Oncology, October 2018, Elsevier

     David Baldwin

145. 
     The continuum of screening and early detection, awareness and faster diagnosis of lung cancer

     Article • Thorax, August 2018, BMJ

     David Baldwin

146. 
     Lung cancer in the UK: addressing geographical inequality and late diagnosis

     Article • The Lancet Oncology, August 2018, Elsevier

     David Baldwin

147. 
     The Fleischner Society 2017 and British Thoracic Society 2015 guidelines for managing pulmonary nodules: keep calm and carry on

     Article • Thorax, June 2018, BMJ

     David Baldwin

148. 
     British Thoracic Society quality standards for the investigation and management of pulmonary nodules

     Article • BMJ Open Respiratory Research, April 2018, BMJ

     David Baldwin

149. 
     Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial

     Article • Translational Lung Cancer Research, April 2018, AME Publishing Company

     David Baldwin

150. 
     Recent advances in the management of lung cancer

     Article • Clinical Medicine, April 2018, Elsevier

     David Baldwin

151. 
     OC-0537: Prophylactic irradiation of tracts (PIT) in patients with pleural mesothelioma: a phase III trial

     Article • Radiotherapy and Oncology, April 2018, Elsevier

     David Baldwin

152. 
     Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients

     Article • Thorax, March 2018, BMJ

     David Baldwin

153. 
     Low-dose CT for lung cancer screening – Authors' reply

     Article • The Lancet Oncology, March 2018, Elsevier

     David Baldwin

154. 
     Chemotherapy prescriptions for small cell lung cancer in England: an analysis of the National Lung Cancer Audit, Systemic Anti-Cancer Therapies and Hospital Episode Statistics databases

     Article • Lung Cancer, January 2018, Elsevier

     David Baldwin

155. 
     Impact of an information-film to promote informed decision-making in individuals taking part in a lung cancer screening demonstration pilot

     Article • Lung Cancer, January 2018, Elsevier

     David Baldwin

156. 
     Prophylactic irradiation of tracts (PIT) in patients with pleural mesothelioma: results of a multicentre phase III trial

     Article • Lung Cancer, January 2018, Elsevier

     David Baldwin

157. 
     What factors are associated with early mortality following the first dose of chemotherapy in small cell lung cancer?

     Article • Lung Cancer, January 2018, Elsevier

     David Baldwin

158. 
     Low dose CT screening for lung cancer

     Article • BMJ, December 2017, BMJ

     David Baldwin

159. 
     European position statement on lung cancer screening

     Article • The Lancet Oncology, December 2017, Elsevier

     David Baldwin

160. 
     S11 Identification and attendance of a high-risk cohort in a lung cancer screening demonstration pilot

     Article • November 2017, BMJ

     David Baldwin

161. 
     S14 Lung cancer risk profiles and eligibility of attendees in a lung cancer screening demonstration pilot

     Article • November 2017, BMJ

     David Baldwin

162. 
     S100 Utility of endobronchial ultrasound-guided transbronchial needle aspiration for pd-l1 testing in patients with nsclc

     Article • November 2017, BMJ

     David Baldwin

163. 
     Impact of radiographer immediate reporting of chest X-rays from general practice on the lung cancer pathway (radioX): study protocol for a randomised control trial

     Article • Trials, November 2017, Springer Science + Business Media

     Angshu Bhowmik, David Baldwin

164. 
     P2.06-005 An Exploration of Attitudes and Barriers to Uptake of Lung Cancer Screening in at Risk Adults in the United Kingdom

     Article • Journal of Thoracic Oncology, November 2017, Elsevier

     David Baldwin

165. 
     P3.05-001 Breath Analysis for Early Detection of Lung Cancer: The LuCID Study

     Article • Journal of Thoracic Oncology, November 2017, Elsevier

     David Baldwin

166. 
     OA 02.03 Prophylactic Irradiation of Tracts (PIT) in Patients with Pleural Mesothelioma: Results of a Multicenter Phase III Trial

     Article • Journal of Thoracic Oncology, November 2017, Elsevier

     David Baldwin

167. 
     Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter?

     Article • Annals of Translational Medicine, October 2017, AME Publishing Company

     David Baldwin

168. 
     Use of Volumetry for Lung Nodule Management: Theory and Practice

     Article • Radiology, September 2017, Radiological Society of North America (RSNA)

     David Baldwin

169. 
     Physician Assessment of Pretest Probability of Malignancy and Adherence to Guidelines for Pulmonary Nodule Evaluation

     Article • CHEST Journal, August 2017, Elsevier

     David Baldwin

170. 
     Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial

     Article • Thorax, July 2017, BMJ

     David Baldwin

171. 
     The impact of trained radiographers as concurrent readers on performance and reading time of experienced radiologists in the UK Lung Cancer Screening (UKLS) trial

     Article • European Radiology, June 2017, Springer Science + Business Media

     David Baldwin

172. 
     Lung cancer in symptomatic patients presenting in primary care: a systematic review of risk prediction tools

     Article • British Journal of General Practice, May 2017, Royal College of General Practitioners

     David Baldwin

173. 
     Is clarithromycin a potential treatment for cachexia in people with lung cancer? A feasibility study

     Article • Lung Cancer, February 2017, Elsevier

     David Baldwin

174. 
     P2.06-035 Exploring Recruitment Factors in a Feasibility Trial of SABR versus Surgery

     Article • Journal of Thoracic Oncology, January 2017, Elsevier

     David Baldwin

175. 
     P1.05-029 SABRTOOTH-A Feasibility Study of SABR Compared to Surgery in Patients with Peripheral Stage I NSCLC Considered to Be at Higher Risk from Surgery

     Article • Journal of Thoracic Oncology, January 2017, Elsevier

     David Baldwin

176. 
     Socioeconomic position and delays in lung cancer diagnosis: should we target the more deprived?

     Article • Thorax, December 2016, BMJ

     David Baldwin

177. 
     S130 The prevalence of undiagnosed copd on spirometry and emphysema on low-dose ct scans in a lung cancer screening demonstration pilot: a teachable moment?

     Article • Thorax, November 2016, BMJ

     David Baldwin

178. 
     What is the Optimum Screening Strategy for the Early Detection of Lung Cancer

     Article • Clinical Oncology, November 2016, Elsevier

     David Baldwin

179. 
     Erratum: Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

     Article • British Journal of Cancer, November 2016, Springer Science + Business Media

     David Baldwin

180. 
     Optimum low dose CT screening interval for lung cancer: the answer from NELSON?

     Article • Thorax, October 2016, BMJ

     David Baldwin

181. 
     Comparing the performance of trained radiographers against experienced radiologists in the UK lung cancer screening (UKLS) trial

     Article • British Journal of Radiology, October 2016, Oxford University Press (OUP)

     David Baldwin

182. 
     Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with periphe...

     Article • Pilot and Feasibility Studies, September 2016, Springer Science + Business Media

     David Baldwin

183. 
     Implementation planning for lung cancer screening: five major challenges

     Article • The Lancet Respiratory Medicine, September 2016, Elsevier

     David Baldwin

184. 
     How should performance in EBUS mediastinal staging in lung cancer be measured?

     Article • British Journal of Cancer, August 2016, Springer Science + Business Media

     David Baldwin

185. 
     Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013

     Article • PLOS One, August 2016, PLOS

     David Baldwin

186. 
     Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial

     Article • Thorax, July 2016, BMJ

     David Baldwin

187. 
     Abstract 3458: UK lung cancer screening trial (UKLS) cost effectiveness: similarities with the NLST high-risk quintiles

     Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

     David Baldwin

188. 
     Defining a standard set of patient-centred outcomes for lung cancer

     Article • European Respiratory Journal, July 2016, European Respiratory Society (ERS)

     David Baldwin

189. 
     Lung cancer risk in new pulmonary nodules: implications for CT screening and nodule management

     Article • The Lancet Oncology, July 2016, Elsevier

     David Baldwin

190. 
     Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data

     Article • British Journal of Cancer, June 2016, Springer Science + Business Media

     David Baldwin

191. 
     Predicting death from surgery for lung cancer: A comparison of two scoring systems in two European countries

     Article • Lung Cancer, May 2016, Elsevier

     David Baldwin

192. 
     The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer

     Article • Health Technology Assessment, May 2016, National Institute for Health Research

     David Baldwin

193. 
     Management of pulmonary nodules according to the 2015 British Thoracic Society guidelines. Key messages for clinical practice

     Article • Polish Archives of Internal Medicine, April 2016, Towarzystwo Internistow Polskich/Polish Society of Internal Medicine

     David Baldwin

194. 
     The Lung Screen Uptake Trial (LSUT): protocol for a randomised controlled demonstration lung cancer screening pilot testing a targeted invitation strategy for high risk and ‘hard-to-reach’ patients

     Article • BMC Cancer, April 2016, Springer Science + Business Media

     David Baldwin

195. 
     Lung cancer: investigation and staging

     Article • Medicine, April 2016, Elsevier

     David Baldwin

196. 
     Return of the pulmonary nodule: the radiologist's key role in implementing the 2015 BTS guidelines on the investigation and management of pulmonary nodules

     Article • British Journal of Radiology, March 2016, Oxford University Press (OUP)

     David Baldwin

197. 
     Pulmonary nodules and CT screening: the past, present and future

     Article • Thorax, February 2016, BMJ

     David Baldwin

198. 
     The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I ...

     Article • Pilot and Feasibility Studies, February 2016, Springer Science + Business Media

     David Baldwin

199. 
     How should pulmonary nodules be optimally investigated and managed?

     Article • Lung Cancer, January 2016, Elsevier

     David Baldwin

200. 
     CT screening for lung cancer: Is the evidence strong enough?

     Article • Lung Cancer, January 2016, Elsevier

     David Baldwin

201. 
     Integrated Raman microscopy and auto-fluorescence imaging for fast tumour diagnosis during cancer surgery

     Article • January 2016, Optical Society of America (OSA)

     David Baldwin

202. 
     Protocol for PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

     Article • BMJ Open, January 2016, BMJ

     David Baldwin

203. 
     Pulmonary nodules again? The 2015 British Thoracic Society guidelines on the investigation and management of pulmonary nodules

     Article • Clinical Radiology, January 2016, Elsevier

     David Baldwin

204. 
     UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening

     Article • Thorax, December 2015, BMJ

     David Baldwin

205. 
     Development of Guidelines for the Management of Pulmonary Nodules Toward Better Implementation

     Article • CHEST Journal, December 2015, Elsevier

     David Baldwin

206. 
     Correction

     Article • Thorax, November 2015, BMJ

     David Baldwin

207. 
     Patients’ attitudes to risk in lung cancer surgery: A qualitative study

     Article • Lung Cancer, November 2015, Elsevier

     Dr Laura Jones, David Baldwin

208. 
     Defining a Standard Set of Patient Centered Outcomes for Patients With Lung Cancer

     Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

     David Baldwin

209. 
     Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators

     Article • European Journal of Cancer, September 2015, Elsevier

     David Baldwin

210. 
     Abstract 4602: Exome sequencing of UKLS lung cancer CT screened early stage cancers

     Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

     David Baldwin

211. 
     Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial

     Article • BMJ Open, July 2015, BMJ

     David Baldwin

212. 
     Prediction of risk of lung cancer in populations and in pulmonary nodules: Significant progress to drive changes in paradigms

     Article • Lung Cancer, July 2015, Elsevier

     David Baldwin

213. 
     Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysis

     Article • BMJ Open Respiratory Research, July 2015, BMJ

     David Baldwin

214. 
     The British Thoracic Society guidelines on the investigation and management of pulmonary nodules

     Article • Thorax, July 2015, BMJ

     David Baldwin

215. 
     British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE

     Article • Thorax, June 2015, BMJ

     David Baldwin

216. 
     Screening for lung cancer

     Article • British Journal of Hospital Medicine, June 2015, Mark Allen Group

     David Baldwin

217. 
     Screening

     Article • June 2015, European Respiratory Society (ERS)

     David Baldwin

218. 
     Plasma lipid biomarker signatures in squamous carcinoma and adenocarcinoma lung cancer patients

     Article • Metabolomics, May 2015, Springer Science + Business Media

     David Baldwin

219. 
     FDG-PET/CT Imaging for Mediastinal Staging in Patients With Potentially Resectable Non–Small Cell Lung Cancer

     Article • JAMA, April 2015, American Medical Association (AMA)

     David Baldwin

220. 
     Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial

     Article • The Lancet Respiratory Medicine, April 2015, Elsevier

     David Baldwin

221. 
     Non-small cell lung cancer in young adults: presentation and survival in the English National Lung Cancer Audit

     Article • QJM, February 2015, Oxford University Press (OUP)

     David Baldwin

222. 
     Author's response: What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

     Article • Thorax, January 2015, BMJ

     David Baldwin

223. 
     183: PIT: a phase III trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention

     Article • Lung Cancer, January 2015, Elsevier

     David Baldwin

224. 
     121: Place and cause of death in patients with lung cancer in the United Kingdom

     Article • Lung Cancer, January 2015, Elsevier

     David Baldwin

225. 
     117: Treatment and survival trends in patients with advanced stage NSCLC: a population based study

     Article • Lung Cancer, January 2015, Elsevier

     David Baldwin

226. 
     174: Validation of a surgical predictive score for 90 day mortality in lung cancer and comparison with Thoracoscore

     Article • Lung Cancer, January 2015, Elsevier

     David Baldwin

227. 
     PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer

     Article • Cochrane Database of Systematic Reviews, November 2014, Wiley

     David Baldwin

228. 
     Next steps and barriers to implementing lung cancer screening with low-dose CT

     Article • British Journal of Radiology, November 2014, Oxford University Press (OUP)

     David Baldwin

229. 
     Brain metastases following radical surgical treatment of non-small cell lung cancer: Is preoperative brain imaging important?

     Article • Lung Cancer, November 2014, Elsevier

     David Baldwin

230. 
     What characteristics of primary care and patients are associated with early death in patients with lung cancer in the UK?

     Article • Thorax, October 2014, BMJ

     David Baldwin

231. 
     The impact of the ‘hub and spoke’ model of care for lung cancer and equitable access to surgery

     Article • Thorax, September 2014, BMJ

     David Baldwin

232. 
     Appetite stimulants for people with cystic fibrosis

     Article • Cochrane Database of Systematic Reviews, July 2014, Wiley

     David Baldwin

233. 
     The European initiative for quality management in lung cancer care

     Article • European Respiratory Journal, March 2014, European Respiratory Society (ERS)

     David Baldwin

234. 
     Lung cancer screening with low dose computed tomography

     Article • BMJ, March 2014, BMJ

     David Baldwin

235. 
     The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening

     Article • Cancer Prevention Research, March 2014, American Association for Cancer Research (AACR)

     David Baldwin

236. 
     Small-Cell Lung Cancer in England: Trends in Survival and Chemotherapy Using the National Lung Cancer Audit

     Article • PLOS One, February 2014, PLOS

     David Baldwin

237. 
     Multidisciplinary team management in thoracic oncology: more than just a concept?

     Article • European Respiratory Journal, February 2014, European Respiratory Society (ERS)

     David Baldwin

238. 
     The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) Response to the USPSTF Recommendations

     Article • Journal of Thoracic Oncology, February 2014, Elsevier

     David Baldwin

239. 
     Effective lung cancer screening is possible

     Article • BMJ, January 2014, BMJ

     David Baldwin

240. 
     Treatment decisions and survival for people with small-cell lung cancer

     Article • British Journal of Cancer, January 2014, Springer Science + Business Media

     David Baldwin

241. 
     129 Fibreoptic bronchoscopic electrocautery for palliation in patients with central lung cancer

     Article • Lung Cancer, January 2014, Elsevier

     David Baldwin

242. 
     176 Less chemotherapy and poor outcomes for people with small-cell lung cancer diagnosed through emergency admission

     Article • Lung Cancer, January 2014, Elsevier

     David Baldwin

243. 
     92 Predictors of early death from lung cancer in primary care

     Article • Lung Cancer, January 2014, Elsevier

     David Baldwin

244. 
     181 Small-cell lung cancer: chemotherapy cycles and survival

     Article • Lung Cancer, January 2014, Elsevier

     David Baldwin

245. 
     66 UK Lung Cancer Screening trial (UKLS): Prevalence data at baseline

     Article • Lung Cancer, January 2014, Elsevier

     David Baldwin

246. 
     CT screening for lung cancer: countdown to implementation

     Article • The Lancet Oncology, December 2013, Elsevier

     David Baldwin

247. 
     P13 Identifying patients who had surgical resection for non-small cell lung cancer using large datasets: Abstract P13 Table 1.

     Article • Thorax, November 2013, BMJ

     David Baldwin

248. 
     P15 Identifying patients who receive chemotherapy for small-cell lung cancer using large datasets

     Article • Thorax, November 2013, BMJ

     David Baldwin

249. 
     P14 Small-cell lung cancer in England: Trends in survival and therapy

     Article • Thorax, November 2013, BMJ

     David Baldwin

250. 
     Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009

     Article • Thorax, October 2013, BMJ

     David Baldwin

251. 
     Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit

     Article • British Journal of Cancer, September 2013, Springer Science + Business Media

     David Baldwin

252. 
     European randomized lung cancer screening trials: Post NLST

     Article • Journal of Surgical Oncology, July 2013, Wiley

     PhD Silvio Cavuto, David Baldwin

253. 
     Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit

     Article • Thorax, May 2013, BMJ

     David Baldwin

254. 
     Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer: The Importance of Smoking and Timing of Diagnosis

     Article • Journal of Thoracic Oncology, April 2013, Elsevier

     David Baldwin

255. 
     Abstract 3631: United Kingdom lung cancer screening trial (UKLS): First 88897 approaches.

     Article • Cancer Research, April 2013, American Association for Cancer Research (AACR)

     David Baldwin

256. 
     The pathological confirmation rate of lung cancer in England using the NLCA database

     Article • Lung Cancer, February 2013, Elsevier

     David Baldwin

257. 
     Using socio-demographic and early clinical features in general practice to identify people with lung cancer earlier

     Article • Thorax, January 2013, BMJ

     David Baldwin

258. 
     Chronic Obstructive Pulmonary Disease and Risk of Lung Cancer: The Importance of Smoking and Timing of Diagnosis

     Article • Journal of Thoracic Oncology, January 2013, Elsevier

     David Baldwin

259. 
     The Association Between Smoking Quantity and Lung Cancer in Men and Women

     Article • CHEST Journal, January 2013, Elsevier

     David Baldwin

260. 
     205 90-day mortality after surgery for lung cancer – An analysis of the National Lung Cancer Audit

     Article • Lung Cancer, January 2013, Elsevier

     David Baldwin

261. 
     208 Attitudes to risk associated with lung cancer – Plan for a qualitative study

     Article • Lung Cancer, January 2013, Elsevier

     David Baldwin

262. 
     63 Is PET-CT sufficient to exclude asymptomatic brain metastases prior to radical surgical treatment for lung cancer?

     Article • Lung Cancer, January 2013, Elsevier

     David Baldwin

263. 
     81 The uniqueness of the United Kingdom Lung Cancer Screening trial (UKLS) – a population screening study

     Article • Lung Cancer, January 2013, Elsevier

     David Baldwin

264. 
     S93 COPD and risk of lung cancer: The importance of smoking and timing of diagnosis of COPD: Abstract S93 Table 1

     Article • Thorax, November 2012, BMJ

     David Baldwin

265. 
     P167 Pathological Confirmation Rate of Lung Cancer in England Using the NLCA Database

     Article • Thorax, November 2012, BMJ

     David Baldwin

266. 
     P202 Risk Factors For Early Mortality After Lung Cancer Resection: A Study of the UK National Lung Cancer Audit: Abstract P202 Table 1

     Article • Thorax, November 2012, BMJ

     David Baldwin

267. 
     Authors' response

     Article • Thorax, August 2012, BMJ

     David Baldwin

268. 
     Measurement Methods and Algorithms for the Management of Solid Nodules

     Article • Journal of Thoracic Imaging, July 2012, Wolters Kluwer Health

     David Baldwin

269. 
     A proposed new imaging pathway for patients with suspected lung cancer

     Article • Clinical Radiology, June 2012, Elsevier

     David Baldwin

270. 
     The (US) National Lung Cancer Screening Trial: intensifying the debate about the introduction of screening for lung cancer

     Article • The Journal of the Royal College of Physicians of Edinburgh, June 2012, SAGE Publications

     David Baldwin

271. 
     What is the Most Effective Follow-up Model for Lung Cancer Patients? A Systematic Review

     Article • Journal of Thoracic Oncology, May 2012, Elsevier

     David Baldwin

272. 
     Lung cancer: investigation and staging

     Article • Medicine, April 2012, Elsevier

     David Baldwin

273. 
     Abstract 3571: UKLS - United Kingdom Lung Cancer Screening Trial

     Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

     David Baldwin

274. 
     Authors' response

     Article • Thorax, February 2012, BMJ

     David Baldwin

275. 
     International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 Report

     Article • Journal of Thoracic Oncology, January 2012, Elsevier

     David Baldwin

276. 
     Supportive Care in Respiratory Disease

     Article • January 2012, Oxford University Press (OUP)

     David Baldwin

277. 
     130 Is chronic obstructive pulmonary disease an independent risk factor for lung cancer?

     Article • Lung Cancer, January 2012, Elsevier

     David Baldwin

278. 
     69 PIT: A phase III trial of prophylactic irradiation of tracks in patients with malignant pleural mesothelioma following invasive chest wall intervention

     Article • Lung Cancer, January 2012, Elsevier

     David Baldwin

279. 
     135 Smoking and lung cancer in women

     Article • Lung Cancer, January 2012, Elsevier

     David Baldwin

280. 
     P153 Measuring variation in decision making within lung cancer multidisciplinary team (MDT) meetings-a pilot study

     Article • Thorax, December 2011, BMJ

     David Baldwin

281. 
     Authors' response

     Article • Thorax, September 2011, BMJ

     David Baldwin

282. 
     How do patient and hospital features influence outcomes in small-cell lung cancer in England?

     Article • British Journal of Cancer, August 2011, Springer Science + Business Media

     David Baldwin

283. 
     Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service

     Article • Thorax, July 2011, BMJ

     David Baldwin

284. 
     CT screening for lung cancer in the UK: position statement by UKLS investigators following the NLST report

     Article • Thorax, July 2011, BMJ

     David Baldwin

285. 
     Diagnosis and treatment of lung cancer: summary of updated NICE guidance

     Article • BMJ, April 2011, BMJ

     David Baldwin

286. 
     Lung cancer in England: Information from the National Lung Cancer Audit (LUCADA)

     Article • Lung Cancer, April 2011, Elsevier

     David Baldwin

287. 
     Imaging in lung cancer: recent advances in PET-CT and screening

     Article • Thorax, March 2011, BMJ

     David Baldwin

288. 
     UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer

     Article • Thorax, February 2011, BMJ

     David Baldwin

289. 
     Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis

     Article • BMJ, January 2011, BMJ

     David Baldwin

290. 
     Authors' response

     Article • Thorax, November 2010, BMJ

     David Baldwin

291. 
     Guidelines on the radical management of patients with lung cancer

     Article • Thorax, October 2010, BMJ

     David Baldwin

292. 
     Diagnosing lung cancer earlier in the UK

     Article • Thorax, August 2010, BMJ

     David Baldwin

293. 
     Technical validation of an autoantibody test for lung cancer

     Article • Annals of Oncology, August 2010, Elsevier

     David Baldwin

294. 
     Cardiopulmonary exercise testing for the selection of patients undergoing surgery for lung cancer: friend or foe?

     Article • Thorax, July 2010, BMJ

     David Baldwin

295. 
     Cytological assessment of conventional transbronchial fine needle aspiration of lymph nodes

     Article • Cytopathology, January 2010, Wiley

     David Baldwin

296. 
     Prevention of skin metastasis in malignant mesothelioma with prophylactic irradiation of tracts (PIT): Is the difference in research evidence due to the discrepancy between distance from pleural entry point and the skin scar?

     Article • Lung Cancer, January 2010, Elsevier

     David Baldwin

297. 
     The National Lung Cancer Audit Database (LUCADA); essential analysis of data quality

     Article • Lung Cancer, January 2009, Elsevier

     David Baldwin

298. 
     Lung cancer: investigation and staging

     Article • Medicine, March 2008, Elsevier

     David Baldwin

299. 
     Appetite stimulants in cystic fibrosis: a systematic review

     Article • Journal of Human Nutrition and Dietetics, November 2007, Wiley

     David Baldwin

300. 
     BTS statement on malignant mesothelioma in the UK, 2007

     Article • Thorax, November 2007, BMJ

     David Baldwin

301. 
     NICE guidance for screening for malnutrition: implications for lung cancer services

     Article • Thorax, September 2007, BMJ

     Dr Andrew M Johnston , David Baldwin

302. 
     Lung cancer outcomes at a UK cancer unit between 1998–2001

     Article • Lung Cancer, August 2007, Elsevier

     David Baldwin

303. 
     Measuring the success of transbronchial needle aspiration in everyday clinical practice

     Article • Respiratory Medicine, March 2007, Elsevier

     David Baldwin

304. 
     Is Transesophageal Echocardiography Necessary before D.C. Cardioversion in Patients with a Normal Transthoracic Echocardiogram?

     Article • Echocardiography, February 2007, Wiley

     David Baldwin

305. 
     Elevated Exhaled Nitric Oxide in Newborns of Atopic Mothers Precedes Respiratory Symptoms

     Article • American Review of Respiratory Disease, December 2006, Oxford University Press (OUP)

     David Baldwin

306. 
     Prospectively assessed incidence, severity, and determinants of respiratory symptoms in the first year of life

     Article • Pediatric Pulmonology, November 2006, Wiley

     David Baldwin

307. 
     Alterations of exhaled nitric oxide in pre-term infants with chronic lung disease

     Article • European Respiratory Journal, October 2006, European Respiratory Society (ERS)

     David Baldwin

308. 
     Noninvasive monitoring of chest wall movement in infants using laser

     Article • Pediatric Pulmonology, July 2006, Wiley

     David Baldwin

309. 
     Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway

     Article • British Journal of Cancer, September 2005, Springer Science + Business Media

     David Baldwin

310. 
     Evaluation of the solitary pulmonary nodule: clinical management, role of CT and nuclear medicine

     Article • Imaging, October 2004, Oxford University Press (OUP)

     David Baldwin

311. 
     Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy

     Article • Journal of Antimicrobial Chemotherapy, November 2002, Oxford University Press (OUP)

     David Baldwin

312. 
     Interpretation of occupational peak flow records: level of agreement between expert clinicians and Oasys-2

     Article • Thorax, October 2002, BMJ

     David Baldwin

313. 
     Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions?

     Article • Thorax, September 2002, BMJ

     David Baldwin

314. 
     Distal esophageal perforation caused by tuberculosis

     Article • Journal of Thoracic and Cardiovascular Surgery, May 2001, Elsevier

     David Baldwin

315. 
     Questionnaire survey of male infertility in cystic fibrosis

     Article • Respiratory Medicine, October 2000, Elsevier

     David Baldwin

316. 
     Glucose uptake increases relative to oxygen consumption during short-term hibernation

     Article • Basic Research in Cardiology, February 2000, Springer Science + Business Media

     David Baldwin

317. 
     Development of an expert system for the interpretation of serial peak expiratory flow measurements in the diagnosis of occupational asthma. Midlands Thoracic Society Research Group.

     Article • Occupational and Environmental Medicine, November 1999, BMJ

     David Baldwin

318. 
     How Do General Practitioners Respond to Reports of Abnormal Chest X-rays?

     Article • Journal of the Royal Society of Medicine, September 1999, SAGE Publications

     David Baldwin

319. 
     Comparison of two new methods for the measurement of lung volumes with two standard methods

     Article • Thorax, April 1999, BMJ

     David Baldwin

320. 
     Efficacy, tolerance, and pharmacokinetics of once daily tobramycin for pseudomonas exacerbations in cystic fibrosis

     Article • Archives of Disease in Childhood, February 1999, BMJ

     David Baldwin

321. 
     Comparative clinical and physiological features of Maori, Pacific Islanders and Europeans with sleep related breathing disorders

     Article • Respirology, December 1998, Wiley

     David Baldwin

322. 
     Effect of two types of mandibular advancement splints on snoring and obstructive sleep apnoea

     Article • European Journal of Orthodontics, June 1998, Oxford University Press (OUP)

     David Baldwin

323. 
     Coronary Bypass Grafting for Single-Vessel Coronary Artery Disease

     Article • CHEST Journal, March 1998, Elsevier

     David Baldwin

324. 
     Pragmatics: Principals of Design and Evaluation of an Information System for a Department of Respiratory Medicine

     Article • Health Care Analysis, March 1997, Wiley

     David Baldwin

325. 
     The Effects of Voluntary Exercise and Immobilization on Humoral Immunity and Endocrine Responses in Rats

     Article • Physiology & Behavior, March 1997, Elsevier

     David Baldwin

326. 
     Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease

     Article • BMJ, January 1997, BMJ

     David Baldwin

327. 
     Silicosis presenting as bilateral hilar lymphadenopathy.

     Article • Thorax, November 1996, BMJ

     David Baldwin

328. 
     Myocardial Glucose Metabolism and ATP Levels Are Decreased Two Days after Global Ischemia

     Article • Journal of Surgical Research, June 1996, Elsevier

     David Baldwin

329. 
     SHORT COMMUNICATION: Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers

     Article • Carcinogenesis, January 1996, Oxford University Press (OUP)

     David Baldwin

330. 
     Effect of diuretics on allergen-induced contractions of passively sensitized human bronchi in vitro.

     Article • American Review of Respiratory Disease, October 1995, American Thoracic Society

     David Baldwin

331. 
     Nocturnal oxygen desaturation and exercise-induced desaturation in subjects with chronic obstructive pulmonary disease

     Article • Respiratory Medicine, October 1995, Elsevier

     David Baldwin

332. 
     Concentrations of ceftibuten in plasma and the respiratory tract following a single 400 mg oral dose

     Article • International Journal of Antimicrobial Agents, April 1995, Elsevier

     David Baldwin

333. 
     Impact of differential housing on humoral immunity following exposure to an acute stressor in rats

     Article • Physiology & Behavior, April 1995, Elsevier

     David Baldwin

334. 
     Scoring system developed for drug related morbidity

     Article • BMJ, January 1995, BMJ

     David Baldwin

335. 
     Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo.

     Article • Thorax, November 1994, BMJ

     David Baldwin

336. 
     The concentration of sparfloxacin in lung tissues after single and multiple oral doses

     Article • International Journal of Antimicrobial Agents, August 1994, Elsevier

     David Baldwin

337. 
     The levels of clarithromycin and its 14-hydroxy metabolite in the lung

     Article • European Respiratory Journal, July 1994, European Respiratory Society (ERS)

     David Baldwin

338. 
     Cross refractoriness between sodium metabisulphite and exercise induced asthma.

     Article • Thorax, March 1994, BMJ

     David Baldwin

339. 
     Effect of addition of exercise to chest physiotherapy on sputum expectoration and lung function in adults with cystic fibrosis

     Article • Respiratory Medicine, January 1994, Elsevier

     David Baldwin

340. 
     The Effect of Sodium Transport and Calcium Channel Inhibitors on Phorbol Ester-induced Contraction of Bovine Airway Smooth Muscle

     Article • Pulmonary Pharmacology, December 1993, Elsevier

     David Baldwin

341. 
     Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration

     Article • Respiratory Medicine, November 1993, Elsevier

     David Baldwin

342. 
     Laparoscopic cholecystectomy in patients with cystic fibrosis

     Article • Respiratory Medicine, April 1993, Elsevier

     David Baldwin

343. 
     Quantitative morphology and water distribution of bronchial biopsy samples.

     Article • Thorax, July 1992, BMJ

     David Baldwin

344. 
     Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

     Article • Antimicrobial Agents and Chemotherapy, June 1992, ASM Journals

     David Baldwin

345. 
     Pulmonary disposition of antimicrobial agents: methodological considerations.

     Article • Antimicrobial Agents and Chemotherapy, June 1992, ASM Journals

     David Baldwin

346. 
     Bronchoalveolar distribution of cefaroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens

     Article • Journal of Antimicrobial Chemotherapy, January 1992, Oxford University Press (OUP)

     David Baldwin

347. 
     Concentrations of cefpodoxime in serum and bronchial mucosal biopsies

     Article • Journal of Antimicrobial Chemotherapy, January 1992, Oxford University Press (OUP)

     David Baldwin

348. 
     The site concentrations of antimicrobial agents in the lung

     Article • Journal of Antimicrobial Chemotherapy, January 1992, Oxford University Press (OUP)

     David Baldwin

349. 
     Microlavage: a technique for determining the volume of epithelial lining fluid.

     Article • Thorax, September 1991, BMJ

     David Baldwin

350. 
     Comparative pharmacokinetic disposition of fluoroquinolones in the lung

     Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

     David Baldwin

351. 
     In-vitro activity and β-lactamase stability of SR 44337, a new long acting cephalosporin

     Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

     David Baldwin

352. 
     In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics

     Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

     David Baldwin

353. 
     The penetration of cefpirome into the potential sites of pulmonary infection

     Article • Journal of Antimicrobial Chemotherapy, January 1991, Oxford University Press (OUP)

     David Baldwin

354. 
     Theophylline analysis at the chest clinic—comparison of a portable versus conventional system

     Article • Respiratory Medicine, January 1991, Elsevier

     David Baldwin

355. 
     AUTHORS' REPLY

     Article • Thorax, December 1990, BMJ

     David Baldwin

356. 
     Concentrations of oral lomefloxacin in serum and bronchial mucosa.

     Article • Antimicrobial Agents and Chemotherapy, June 1990, ASM Journals

     David Baldwin

357. 
     Concentrations of temafloxacin in serum and bronchial mucosa

     Article • European Journal of Clinical Microbiology & Infectious Diseases, June 1990, Springer Science + Business Media

     David Baldwin

358. 
     Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.

     Article • Thorax, May 1990, BMJ

     David Baldwin

359. 
     Changes in hospital management of acute severe asthma by thoracic and general physicians in Birmingham and Manchester during 1978 and 1985.

     Article • Thorax, February 1990, BMJ

     David Baldwin

360. 
     Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose

     Article • Journal of Antimicrobial Chemotherapy, January 1990, Oxford University Press (OUP)

     David Baldwin